UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Baekje to distribute Leo Pharma's dermatology products
Baekje Pharmaceutical said that it would exclusively distribute all of Leo ...
by Lee Han-soo
|
2020-06-09 16:49
라인
LegoChem licenses in Covid-19 treatment candidates
LegoChem BioScience licensed in two Covid-19 treatment candidates from the ...
by Lee Han-soo
|
2020-06-09 16:48
라인
MSD Korea’s privacy breach controversy resurfaces
MSD Korea’s “Self-Assurance Program (SAP),” recording conversations of doct...
by Kim Yun-mi
|
2020-06-09 11:26
라인
Korean, US firms in legal battle over Covid-19 vaccine know-how
A legal dispute is underway between American vaccine maker Inovio and VGXI,...
by Lee Han-soo
|
2020-06-08 21:28
라인
Drug sales reps move briskly amid worries over Covid-19 resurge
Visits by pharmaceutical sales representatives to doctors have begun to reb...
by Kim Yun-mi
|
2020-06-08 15:52
라인
Kainos nears end of HIV drug’s clinical trials in China
Kainos Medicine said Friday it has completed the administration of a human ...
by Shim Hyun-tai
|
2020-06-05 17:40
라인
Rinvoq joins competition among JAK inhibitors
AbbVie Korea has obtained approval for rheumatoid arthritis treatment Rinvo...
by Kim Yun-mi
|
2020-06-05 16:16
라인
IVI ties up with SNUH for clinical trial of Covid-19 vaccine
The International Vaccine Institute (IVI) and Seoul National University Hos...
by Lee Han-soo
|
2020-06-04 17:04
라인
Huons’ dry eye drop scores German nod for clinical trial
Huons said Thursday that the German Federal Institute for Drugs and Medical...
by Shim Hyun-tai
|
2020-06-04 16:25
라인
MedPacto to test Vactosertib for treating NSCLC
MedPacto has applied for phase 2 clinical trials concerning the combined us...
by Lee Han-soo
|
2020-06-04 12:43
라인
Dupixent to provide new treatment options for asthma patients
Sanofi-Aventis Korea said Wednesday it would enter the local asthma drug ma...
by Lee Han-soo
|
2020-06-03 17:54
라인
CDK 4/6 inhibitor market to heat up on insurance benefits
Hormone receptor (HR) positive, human epidermal growth factor receptor 2 (H...
by Lee Han-soo
|
2020-06-02 17:13
라인
‘Keytruda doubled survival in advanced colon cancer compared to chemo’
MSD’s Keytruda (ingredient: pembrolizumab) extended the progression-free su...
by Kim Yun-mi
|
2020-06-02 11:27
라인
Huons to supply emergency drugs to global market
Huons said Monday that it would export anesthesia and sedatives, such as in...
by Shim Hyun-tai
|
2020-06-01 15:26
라인
'Lazertinib showed effect on lung cancer, brain metastasis'
Yuhan Corp. said its investigational anticancer drug Lazertinib has proved ...
by Park Gi-taek
|
2020-06-01 14:08
라인
Il-yang wins Russia’s nod to test potential Covid-19 drug in phase-3 study
Il-yang Pharmaceutical said it has obtained Russian approval to evaluate it...
by Park Gi-taek
|
2020-05-29 16:57
라인
Heathcare experts shun online meetings: survey
The spread of the new coronavirus infections generated a rising trend of no...
by Kim Yun-mi
|
2020-05-29 16:55
라인
Kisqali offers survival benefit to breast cancer patients with visceral metastases
Novartis’ Kisqali, a treatment for metastatic breast cancer, showed a consi...
by Kim Yun-mi
|
2020-05-29 10:58
라인
Kolmar Korea sells off its pharma business to IMM Private Equity
Kolmar Korea said it would sell its pharmaceutical business unit and Kolmar...
by Lee Han-soo
|
2020-05-28 12:11
라인
[News Focus] Remdesivir alone not enough to kill Covid-19
Remdesivir has emerged as the drug to treat the new coronavirus infection, ...
by Kim Yun-mi
|
2020-05-27 14:20
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top